查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1571959

全球心臟定位市场

Cardiac Mapping
出版日期: | 出版商: Global Industry Analysts, Inc. | 英文 93 Pages | 商品交期: 最快1-2个工作天内

价格

※ 本网页内容可能与最新版本有所差异。详细情况请与我们联繫。

简介目录

到 2030 年，全球心臟定位市场将达到 37 亿美元

2023 年全球心臟定位市场预计为 22 亿美元，预计到 2030 年将达到 37 亿美元，2023-2030 年分析期间复合年增长率为 7.7%。心房颤动适应症是本报告分析的细分市场之一，预计复合年增长率为 7.1%，到分析期结束时将达到 12 亿美元。在分析期间，心房扑动适应症领域的复合年增长率估计为 8.5%。

美国市场预估价值5.77亿美元，中国预期复合年增长率11.5%

到 2023 年，美国心臟定位市场预计将达到 5.77 亿美元。中国作为世界第二大经济体，预计到 2030 年市场规模将达到 9.098 亿美元，2023-2030 年分析期间复合年增长率为 11.5%。其他值得注意的区域市场包括日本和加拿大，在分析期间预计复合年增长率分别为 4.0% 和 6.7%。在欧洲，德国的复合年增长率预计为 4.6%。

全球心臟定位市场 - 主要趋势和驱动因素总结

什么是心臟定位？

心臟定位是一种先进的医疗技术，用于可视化心臟的电活动，以识别和治疗心律不整，如心房颤动、心室心搏过速和其他异常心律。这项技术使心臟科医师能够创建心臟电传导系统的详细3D图，提供有关异常电讯号来源的精确资讯。心臟定位透过找出导致心律不整的部位来帮助指导治疗性介入，例如心导管电气烧灼术，并且已成为现代电生理学的重要工具。

全世界心血管疾病 (CVD)，特别是心律不整的盛行率不断增加，增加了对有效诊断和治疗工具（例如心臟定位）的需求。心臟定位提供的精确度可以实现更准确的诊断，降低治疗无效的风险，并最大限度地减少手术的侵入性。此外，心臟定位越来越多地用于传统诊断方法不足以确定心律不整根本原因的复杂病例。对先进诊断的日益依赖使得心臟定位成为心臟治疗的重要组成部分。

技术进步如何形塑心臟定位市场？

技术的进步彻底改变了心臟定位市场，导致了更复杂、更准确和用户友好的系统的开发。三维 (3D) 电解剖测绘系统的引入极大地提高了医生即时可视化心臟电途径的能力。这些系统整合了来自各种来源的资料，包括导管、感测器和显像模式，以创建高度详细的地图，以令人难以置信的精度指导干预措施。例如，CARTO 3 系统和 EnSite Precision 系统等系统改变了复杂心律不整的诊断和治疗方式。

此外，体表测绘 (BSM) 等非侵入性测绘技术的进步越来越受欢迎，该技术无需侵入性导管即可进行详细的心臟定位。这不仅提高了患者的舒适度，而且扩大了早期诊断和后续观察中绘图的应用范围。人工智慧 (AI) 和机器学习演算法的兴起透过提高讯号解释的准确性，进一步增强心臟定位的能力，从而实现更快、更准确的诊断。这些创新使心臟定位在临床实践中更有效率、更容易获得和更有价值，从而在世界各地的医院和心臟中心得到采用。

哪些患者和医疗保健趋势正在推动心臟定位的需求？

一些患者和医疗保健趋势正在影响对心臟定位技术的需求。心血管疾病尤其是心律不整发生率的增加是主要促进因素之一。由于世界人口老化以及高血压、肥胖和久坐生活方式等危险因子的增加，心律不整的盛行率正在增加。随着越来越多的患者被诊断出患有心房颤动和心室心搏过速等疾病，对先进诊断工具提供准确有效治疗方法的需求也在增加，对心臟定位系统的依赖也在增加。

另一个重要趋势是越来越重视个人化医疗。现今的患者期望针对其特定医疗状况获得更量身定制的治疗。心臟定位使循环系统能够透过找出心律不整的原因并对心臟的特定区域进行针对性治疗来提供客製化治疗。此外，由于患者对更快恢復时间、更少疼痛和更少併发症的偏好，对微创治疗的需求正在增加。心臟定位，特别是引导管消融，透过为心律不整治疗提供微创且高效的解决方案，顺应了这一趋势。随着患者期望和医疗保健服务的发展，对心臟定位等精确诊断的需求持续增长。

心臟定位市场的成长受到多种因素的推动。

心臟定位市场的成长是由多种因素推动的，例如心血管疾病盛行率的增加、电生理技术的进步以及对微创手术的需求不断增长。关键驱动因素之一是越来越多的患者被诊断出患有心律不整和其他心律不整。随着全球心律不整患者数量的增加，特别是由于生活方式和老化，越来越需要有效的诊断工具来帮助心臟科医师准确地绘製心臟的电活动图并提供有针对性的治疗。

心臟定位系统的技术进步也推动了市场的成长。 3D电解剖测绘系统、非侵入性体表测绘和人工智慧诊断工具的发展正在提高心律不整诊断和治疗的准确性和效率。这些创新使医院和专科中心更容易使用心臟定位系统，进一步扩大了市场。此外，心导管电气烧灼术（一种用于治疗心律不整的微创手术）的日益普及也推动了对心臟定位技术的需求，以高精度指导这些手术。

此外，对个人化医疗和精准医疗的日益关注也是推动市场成长的重要因素。心臟定位可以根据每位患者的个人心臟状况制定治疗策略，从而改善治疗结果并减少再次手术的需要。此外，随着世界各地的医疗保健系统致力于改善患者照护和减轻心血管疾病的负担，心臟定位正在成为提供更有效和个人化的心臟护理的重要工具。预计这些趋势将在未来几年继续推动心臟定位市场的成长。

受访企业范例（共42例）

  • Abbott Laboratories
  • Acutus Medical
  • Angiodynamics
  • APN Health, LLC
  • Biosense Webster, Inc.（A Johnson & Johnson Company）
  • Biosig Technologies, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Catheter Precision, Inc.
  • Coremap
  • EP Solutions Sa
  • Epmap-System
  • Kardium, Inc.
  • Koninklijke Philips NV
  • Lepu Medical
  • Medtronic Plc
  • Microport Scientific Corporation

目录

第一章调查方法

第 2 章执行摘要

  • 市场概况
  • 主要企业
  • 市场趋势和驱动因素
  • 全球市场展望

第三章市场分析

  • 美国
  • 加拿大
  • 日本
  • 中国
  • 欧洲
  • 法国
  • 德国
  • 义大利
  • 英国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 澳洲
  • 印度
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 阿根廷
  • 巴西
  • 墨西哥
  • 其他拉丁美洲
  • 中东
  • 伊朗
  • 以色列
  • 沙乌地阿拉伯
  • 阿拉伯聯合大公国
  • 其他中东地区
  • 非洲

第四章 比赛

简介目录
Product Code: MCP21435

Global Cardiac Mapping Market to Reach US$3.7 Billion by 2030

The global market for Cardiac Mapping estimated at US$2.2 Billion in the year 2023, is expected to reach US$3.7 Billion by 2030, growing at a CAGR of 7.7% over the analysis period 2023-2030. Atrial Fibrillation Indication, one of the segments analyzed in the report, is expected to record a 7.1% CAGR and reach US$1.2 Billion by the end of the analysis period. Growth in the Atrial Flutter Indication segment is estimated at 8.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$577.0 Million While China is Forecast to Grow at 11.5% CAGR

The Cardiac Mapping market in the U.S. is estimated at US$577.0 Million in the year 2023. China, the world's second largest economy, is forecast to reach a projected market size of US$909.8 Million by the year 2030 trailing a CAGR of 11.5% over the analysis period 2023-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 4.0% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.6% CAGR.

Global Cardiac Mapping Market – Key Trends & Drivers Summarized

What Is Cardiac Mapping and Why Is It Essential in Modern Cardiology?

Cardiac mapping is an advanced medical technique used to visualize the electrical activity of the heart to identify and treat arrhythmias, such as atrial fibrillation, ventricular tachycardia, and other abnormal heart rhythms. This technique allows cardiologists to create detailed, three-dimensional maps of the heart’s electrical conduction system, offering precise information about the source of abnormal electrical signals. By pinpointing the locations responsible for arrhythmias, cardiac mapping helps guide therapeutic interventions such as catheter ablation, making it an essential tool in modern electrophysiology.

With the rising prevalence of cardiovascular diseases (CVDs) globally, particularly arrhythmias, the need for effective diagnosis and treatment tools like cardiac mapping is growing. The precision that cardiac mapping provides allows for more accurate diagnoses, reducing the risk of ineffective treatments and minimizing the invasiveness of procedures. Additionally, cardiac mapping is increasingly used in complex cases where traditional diagnostic methods may not be sufficient to determine the root cause of the arrhythmia. This growing reliance on sophisticated diagnostics is making cardiac mapping an indispensable part of cardiac care.

How Are Technological Advancements Shaping the Cardiac Mapping Market?

Technological advancements are revolutionizing the cardiac mapping market, leading to the development of more sophisticated, accurate, and user-friendly systems. The introduction of three-dimensional (3D) electroanatomical mapping systems has significantly enhanced the ability of physicians to visualize the heart's electrical pathways in real-time. These systems integrate data from various sources, such as catheters, sensors, and imaging modalities, to generate highly detailed maps that guide interventions with remarkable precision. For example, systems like the CARTO 3 system and the EnSite Precision system have transformed the way complex arrhythmias are diagnosed and treated.

Moreover, advancements in non-invasive mapping technologies, such as body surface mapping (BSM), are gaining traction as they allow for detailed cardiac mapping without the need for invasive catheterization. This not only improves patient comfort but also broadens the application of mapping in early diagnosis and follow-up care. The rise of artificial intelligence (AI) and machine learning algorithms is further enhancing the capabilities of cardiac mapping by improving the accuracy of signal interpretation, enabling faster and more accurate diagnoses. These technological innovations are making cardiac mapping more efficient, accessible, and valuable in clinical practice, driving its adoption in hospitals and specialized cardiac centers worldwide.

What Patient and Healthcare Trends Are Driving the Demand for Cardiac Mapping?

Several patient and healthcare trends are influencing the demand for cardiac mapping technologies. The increasing incidence of cardiovascular diseases, particularly arrhythmias, is one of the primary drivers. With an aging global population and rising risk factors such as hypertension, obesity, and sedentary lifestyles, the prevalence of heart rhythm disorders is on the rise. As more patients are diagnosed with conditions like atrial fibrillation and ventricular tachycardia, the need for advanced diagnostic tools that offer precise and effective treatment options is growing, leading to greater reliance on cardiac mapping systems.

Another key trend is the growing emphasis on personalized medicine. Patients today expect more tailored treatments that cater to their specific medical conditions. Cardiac mapping enables cardiologists to deliver customized therapies by accurately identifying the source of arrhythmias and targeting specific areas of the heart for treatment. Additionally, there is an increasing demand for minimally invasive procedures, driven by patients' preferences for shorter recovery times, reduced pain, and fewer complications. Cardiac mapping, particularly in guiding catheter ablation, aligns with this trend by offering a minimally invasive yet highly effective solution for treating arrhythmias. As patient expectations and healthcare delivery evolve, the demand for precision diagnostics like cardiac mapping continues to grow.

Growth in the Cardiac Mapping Market Is Driven by Several Factors

Growth in the cardiac mapping market is driven by several factors, including the increasing prevalence of cardiovascular diseases, advancements in electrophysiology technologies, and the rising demand for minimally invasive procedures. One of the key drivers is the growing number of patients diagnosed with arrhythmias and other heart rhythm disorders. As arrhythmia cases rise globally, particularly due to lifestyle factors and aging populations, there is an increasing need for effective diagnostic tools that enable cardiologists to accurately map the heart’s electrical activity and guide precise treatments.

Technological advancements in cardiac mapping systems are also fueling market growth. The development of 3D electroanatomical mapping systems, non-invasive body surface mapping, and AI-powered diagnostic tools is improving the accuracy and efficiency of arrhythmia diagnosis and treatment. These innovations are making cardiac mapping systems more accessible to hospitals and specialized centers, further expanding the market. Additionally, the increasing adoption of catheter ablation, a minimally invasive procedure used to treat arrhythmias, is boosting demand for cardiac mapping technologies that assist in guiding these procedures with high precision.

Another key factor driving market growth is the rising focus on personalized and precision medicine. Cardiac mapping allows for tailored treatment strategies based on the specific characteristics of each patient’s heart condition, improving outcomes and reducing the need for repeat procedures. Furthermore, as healthcare systems worldwide focus on improving patient care and reducing the burden of cardiovascular diseases, cardiac mapping is becoming a crucial tool in providing more effective and personalized cardiac care. These trends are expected to continue fueling the growth of the cardiac mapping market in the coming years.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories
  • Acutus Medical
  • Angiodynamics
  • APN Health, LLC
  • Biosense Webster, Inc. (A Johnson & Johnson Company)
  • Biosig Technologies, Inc.
  • Biotronik
  • Boston Scientific Corporation
  • Catheter Precision, Inc.
  • Coremap
  • EP Solutions Sa
  • Epmap-System
  • Kardium, Inc.
  • Koninklijke Philips N.V.
  • Lepu Medical
  • Medtronic Plc
  • Microport Scientific Corporation

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • World Market Trajectories
    • Global Economic Update
    • Cardiac Mapping - Global Key Competitors Percentage Market Share in 2024 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2024 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Rising Prevalence of Cardiovascular Diseases Globally Drives Demand for Advanced Cardiac Mapping Solutions in Diagnosis and Treatment
    • Increasing Demand for Minimally Invasive Cardiac Procedures Strengthens Market Position of Advanced Cardiac Mapping Technologies
    • Technological Advancements in 3D Mapping and Real-Time Visualization Propel Adoption of Cardiac Mapping in Electrophysiology
    • Growing Focus on Personalized Medicine and Precision Cardiology Expands Addressable Market for Cardiac Mapping Solutions
    • Rising Adoption of Cardiac Mapping in Atrial Fibrillation Treatment Creates New Growth Opportunities in Cardiology
    • Improving Accuracy and Resolution in Mapping Systems Drives Demand for High-Definition Cardiac Mapping in Complex Arrhythmias
    • Growing Integration of Cardiac Mapping with Robotic-Assisted Catheter Navigation Enhances Precision in Cardiac Interventions
    • Increasing Number of Cardiac Electrophysiology Labs and Specialty Clinics Expands Market Potential for Cardiac Mapping Systems
    • Rising Patient Awareness of Arrhythmia Risks and Treatments Drives Demand for Non-Invasive Cardiac Mapping Technologies
    • Development of Portable and Wearable Mapping Solutions for Continuous Monitoring Spurs Growth in Home and Outpatient Cardiac Care
    • Growing Use of Artificial Intelligence in Mapping Algorithms Enhances Efficiency and Predictive Capabilities of Cardiac Mapping Systems
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Cardiac Mapping by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 3: World 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2014, 2024 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Atrial Fibrillation by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 6: World 16-Year Perspective for Atrial Fibrillation by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Atrial Flutter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Atrial Flutter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 9: World 16-Year Perspective for Atrial Flutter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for AVNRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 11: World Historic Review for AVNRT by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 12: World 16-Year Perspective for AVNRT by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Other Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Other Arrhythmias by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 15: World 16-Year Perspective for Other Arrhythmias by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 18: World 16-Year Perspective for Contact Cardiac Mapping Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 19: World Recent Past, Current & Future Analysis for Non-Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 20: World Historic Review for Non-Contact Cardiac Mapping Systems by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 21: World 16-Year Perspective for Non-Contact Cardiac Mapping Systems by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2014, 2024 & 2030
    • TABLE 22: World Cardiac Mapping Market Analysis of Annual Sales in US$ Thousand for Years 2014 through 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2024 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 25: USA 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 28: USA 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 31: Canada 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 34: Canada 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • JAPAN
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2024 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 37: Japan 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 40: Japan 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • CHINA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2024 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 43: China 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 46: China 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • EUROPE
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2024 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Cardiac Mapping by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 49: Europe 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2014, 2024 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 52: Europe 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 55: Europe 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • FRANCE
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2024 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 58: France 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 61: France 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • GERMANY
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2024 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 64: Germany 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 67: Germany 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 70: Italy 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 73: Italy 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • UNITED KINGDOM
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2024 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 76: UK 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 79: UK 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • SPAIN
    • TABLE 80: Spain Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 81: Spain Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 82: Spain 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 83: Spain Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 84: Spain Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 85: Spain 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • RUSSIA
    • TABLE 86: Russia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 87: Russia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 88: Russia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 89: Russia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 90: Russia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 91: Russia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF EUROPE
    • TABLE 92: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 93: Rest of Europe Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 94: Rest of Europe 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 95: Rest of Europe Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 96: Rest of Europe Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 97: Rest of Europe 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ASIA-PACIFIC
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2024 (E)
    • TABLE 98: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 99: Asia-Pacific Historic Review for Cardiac Mapping by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 100: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2014, 2024 & 2030
    • TABLE 101: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 102: Asia-Pacific Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 103: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 106: Asia-Pacific 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • AUSTRALIA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2024 (E)
    • TABLE 107: Australia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 108: Australia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 109: Australia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 110: Australia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 111: Australia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 112: Australia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • INDIA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2024 (E)
    • TABLE 113: India Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 114: India Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 115: India 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 116: India Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 117: India Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 118: India 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • SOUTH KOREA
    • TABLE 119: South Korea Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 120: South Korea Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 121: South Korea 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 122: South Korea Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 123: South Korea Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 124: South Korea 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 125: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 126: Rest of Asia-Pacific Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 127: Rest of Asia-Pacific 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 128: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 129: Rest of Asia-Pacific Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 130: Rest of Asia-Pacific 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • LATIN AMERICA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2024 (E)
    • TABLE 131: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 132: Latin America Historic Review for Cardiac Mapping by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 133: Latin America 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2014, 2024 & 2030
    • TABLE 134: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 135: Latin America Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 136: Latin America 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 139: Latin America 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ARGENTINA
    • TABLE 140: Argentina Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 141: Argentina Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 142: Argentina 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 143: Argentina Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 144: Argentina Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 145: Argentina 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • BRAZIL
    • TABLE 146: Brazil Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 147: Brazil Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 148: Brazil 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 149: Brazil Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 150: Brazil Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 151: Brazil 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • MEXICO
    • TABLE 152: Mexico Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 153: Mexico Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 154: Mexico 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 155: Mexico Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 156: Mexico Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 157: Mexico 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF LATIN AMERICA
    • TABLE 158: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 159: Rest of Latin America Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 160: Rest of Latin America 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 161: Rest of Latin America Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 162: Rest of Latin America Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 163: Rest of Latin America 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • MIDDLE EAST
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2024 (E)
    • TABLE 164: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2023 through 2030 and % CAGR
    • TABLE 165: Middle East Historic Review for Cardiac Mapping by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 166: Middle East 16-Year Perspective for Cardiac Mapping by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2014, 2024 & 2030
    • TABLE 167: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 168: Middle East Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 169: Middle East 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 172: Middle East 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • IRAN
    • TABLE 173: Iran Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 174: Iran Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 175: Iran 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 176: Iran Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 177: Iran Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 178: Iran 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • ISRAEL
    • TABLE 179: Israel Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 180: Israel Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 181: Israel 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 182: Israel Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 183: Israel Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 184: Israel 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • SAUDI ARABIA
    • TABLE 185: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 186: Saudi Arabia Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 187: Saudi Arabia 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 188: Saudi Arabia Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 189: Saudi Arabia Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 190: Saudi Arabia 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 191: UAE Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 192: UAE Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 193: UAE 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 194: UAE Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 195: UAE Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 196: UAE 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • REST OF MIDDLE EAST
    • TABLE 197: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 198: Rest of Middle East Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 199: Rest of Middle East 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 200: Rest of Middle East Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 201: Rest of Middle East Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 202: Rest of Middle East 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030
  • AFRICA
    • Cardiac Mapping Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2024 (E)
    • TABLE 203: Africa Recent Past, Current & Future Analysis for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 204: Africa Historic Review for Cardiac Mapping by Indication - Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 205: Africa 16-Year Perspective for Cardiac Mapping by Indication - Percentage Breakdown of Value Sales for Atrial Fibrillation, Atrial Flutter, AVNRT and Other Arrhythmias for the Years 2014, 2024 & 2030
    • TABLE 206: Africa Recent Past, Current & Future Analysis for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems - Independent Analysis of Annual Sales in US$ Thousand for the Years 2023 through 2030 and % CAGR
    • TABLE 207: Africa Historic Review for Cardiac Mapping by Product - Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2014 through 2022 and % CAGR
    • TABLE 208: Africa 16-Year Perspective for Cardiac Mapping by Product - Percentage Breakdown of Value Sales for Contact Cardiac Mapping Systems and Non-Contact Cardiac Mapping Systems for the Years 2014, 2024 & 2030

IV. COMPETITION